Singapore, Nov. 11 -- Onward Therapeutics has announced the completion of a share exchange, under which Onward Therapeutics, Inc. (Onward Taiwan) has become the group's global holding and headquarters, while Onward TherapeuticsSA (Onward Switzerland) has become a wholly owned subsidiary of Onward Taiwan.

The group reorganisation involved the exchange of all shares in the former Swiss parent company for shares in the new Taiwan entity, maintaining ownership ratios and board composition.

This milestone marks a strategic step in aligning Onward's global operations and expanding its presence across Asia and Europe. The Taiwan entity brings together Onward's scientific and corporate teams across Taiwan, Switzerland, and France under a unifie...